Alectinib will be administrated under fast conditions.
The primary endpoint of the phase II part was ORR. Other secondary endpoints in phase II are
progression-free survival (PFS), overall survival (OS), intracranial response (ICR), and
duration of response (DOR).
Exploratory endpoints in this follow-up analysis included the evaluation of the correlation
between tumor shrinkage and PFS and chosen dose to relieve cancer symptoms.
Instituto Nacional de Cancerologia de Mexico
1Research sites
45Patients around the world
This study is for people with
Lung cancer
Non-small cell lung carcinoma
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
Instituto Nacional de Cancerología - Ciudad de México
Recruiting
Avenida San Fernando 22, México DF
SponsorInstituto Nacional de Cancerologia de Mexico
